(GIL) Gildan Activewear - Ratings and Ratios
T-Shirts, Fleece, Socks, Underwear, Polos
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 1.42% |
| Yield on Cost 5y | 3.58% |
| Yield CAGR 5y | 18.27% |
| Payout Consistency | 95.5% |
| Payout Ratio | 26.7% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 30.8% |
| Value at Risk 5%th | 45.5% |
| Relative Tail Risk | -10.28% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.04 |
| Alpha | 21.11 |
| CAGR/Max DD | 0.95 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.405 |
| Beta | 0.917 |
| Beta Downside | 0.894 |
| Drawdowns 3y | |
|---|---|
| Max DD | 31.28% |
| Mean DD | 6.42% |
| Median DD | 5.20% |
Description: GIL Gildan Activewear January 07, 2026
Gildan Activewear Inc. (NYSE:GIL) is a vertically integrated apparel manufacturer that produces a broad portfolio of activewear, casual clothing, hosiery, and underwear under its own brands-including Gildan, Champion, and American Apparel-as well as private-label contracts for lifestyle brands. Its distribution network reaches wholesale partners, screen-printers, and retailers across North America, Europe, Asia-Pacific, and Latin America, covering mass merchants, department stores, specialty shops, and e-commerce channels.
Key operating metrics that analysts watch include a 2023 revenue of $2.8 billion with a 5-year CAGR of roughly 6 % (driven by strong athleisure demand), an average gross margin of 30 % (sensitive to cotton and synthetic fiber price volatility), and inventory turnover of 4.2 times, indicating efficient supply-chain management. The company’s earnings per share have grown at an annualized 8 % rate, while its free cash flow conversion consistently exceeds 80 % of net income, supporting dividend sustainability. Primary economic drivers are consumer discretionary spending trends, the ongoing shift toward “work-from-home” and athleisure apparel, and input-cost exposure to commodity (cotton, polyester) and labor rates in low-cost manufacturing hubs.
For a deeper, data-driven look at GIL’s valuation assumptions and scenario outcomes, the ValueRay platform provides a concise analytical snapshot worth reviewing.
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income (473.7m TTM) > 0 and > 6% of Revenue (6% = 201.0m TTM) |
| FCFTA 0.09 (>2.0%) and ΔFCFTA -1.19pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 33.31% (prev 33.49%; Δ -0.17pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.12 (>3.0%) and CFO 490.3m > Net Income 473.7m (YES >=105%, WARN >=100%) |
| Net Debt (1.76b) to EBITDA (844.8m) ratio: 2.08 <= 3.0 (WARN <= 3.5) |
| Current Ratio 2.01 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (150.8m) change vs 12m ago -6.34% (target <= -2.0% for YES) |
| Gross Margin 31.69% (prev 30.45%; Δ 1.25pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 85.84% (prev 86.52%; Δ -0.68pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 4.76 (EBITDA TTM 844.8m / Interest Expense TTM 150.2m) >= 6 (WARN >= 3) |
Altman Z'' 4.53
| (A) 0.27 = (Total Current Assets 2.22b - Total Current Liabilities 1.11b) / Total Assets 4.07b |
| (B) 0.28 = Retained Earnings (Balance) 1.15b / Total Assets 4.07b |
| (C) 0.18 = EBIT TTM 714.5m / Avg Total Assets 3.90b |
| (D) 0.55 = Book Value of Equity 1.42b / Total Liabilities 2.58b |
| Total Rating: 4.53 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 71.63
| 1. Piotroski 6.0pt |
| 2. FCF Yield 2.79% |
| 3. FCF Margin 11.11% |
| 4. Debt/Equity 1.26 |
| 5. Debt/Ebitda 2.08 |
| 6. ROIC - WACC (= 9.95)% |
| 7. RoE 32.81% |
| 8. Rev. Trend 11.37% |
| 9. EPS Trend -18.83% |
What is the price of GIL shares?
Over the past week, the price has changed by +0.92%, over one month by +9.90%, over three months by +3.65% and over the past year by +37.56%.
Is GIL a buy, sell or hold?
- Strong Buy: 6
- Buy: 6
- Hold: 1
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the GIL price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 77.6 | 22.1% |
| Analysts Target Price | 77.6 | 22.1% |
| ValueRay Target Price | 78.4 | 23.5% |
GIL Fundamental Data Overview January 02, 2026
P/E Forward = 13.8889
P/S = 3.4398
P/B = 7.8069
P/EG = 0.6574
Beta = 1.123
Revenue TTM = 3.35b USD
EBIT TTM = 714.5m USD
EBITDA TTM = 844.8m USD
Long Term Debt = 1.30b USD (from longTermDebt, last quarter)
Short Term Debt = 468.6m USD (from shortTermDebt, last quarter)
Debt = 1.87b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.76b USD (from netDebt column, last quarter)
Enterprise Value = 13.32b USD (11.57b + Debt 1.87b - CCE 112.6m)
Interest Coverage Ratio = 4.76 (Ebit TTM 714.5m / Interest Expense TTM 150.2m)
FCF Yield = 2.79% (FCF TTM 372.2m / Enterprise Value 13.32b)
FCF Margin = 11.11% (FCF TTM 372.2m / Revenue TTM 3.35b)
Net Margin = 14.14% (Net Income TTM 473.7m / Revenue TTM 3.35b)
Gross Margin = 31.69% ((Revenue TTM 3.35b - Cost of Revenue TTM 2.29b) / Revenue TTM)
Gross Margin QoQ = 33.10% (prev 31.51%)
Tobins Q-Ratio = 3.27 (Enterprise Value 13.32b / Total Assets 4.07b)
Interest Expense / Debt = 3.06% (Interest Expense 57.2m / Debt 1.87b)
Taxrate = 19.03% (27.9m / 146.8m)
NOPAT = 578.6m (EBIT 714.5m * (1 - 19.03%))
Current Ratio = 2.01 (Total Current Assets 2.22b / Total Current Liabilities 1.11b)
Debt / Equity = 1.26 (Debt 1.87b / totalStockholderEquity, last quarter 1.49b)
Debt / EBITDA = 2.08 (Net Debt 1.76b / EBITDA 844.8m)
Debt / FCF = 4.72 (Net Debt 1.76b / FCF TTM 372.2m)
Total Stockholder Equity = 1.44b (last 4 quarters mean from totalStockholderEquity)
RoA = 12.14% (Net Income 473.7m / Total Assets 4.07b)
RoE = 32.81% (Net Income TTM 473.7m / Total Stockholder Equity 1.44b)
RoCE = 26.00% (EBIT 714.5m / Capital Employed (Equity 1.44b + L.T.Debt 1.30b))
RoIC = 18.38% (NOPAT 578.6m / Invested Capital 3.15b)
WACC = 8.43% (E(11.57b)/V(13.44b) * Re(9.39%) + D(1.87b)/V(13.44b) * Rd(3.06%) * (1-Tc(0.19)))
Discount Rate = 9.39% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -6.31%
[DCF Debug] Terminal Value 75.46% ; FCFF base≈377.9m ; Y1≈345.7m ; Y5≈306.9m
Fair Price DCF = 18.32 (EV 5.15b - Net Debt 1.76b = Equity 3.39b / Shares 185.2m; r=8.43% [WACC]; 5y FCF grow -10.66% → 3.0% )
EPS Correlation: -18.83 | EPS CAGR: -47.50% | SUE: -4.0 | # QB: 0
Revenue Correlation: 11.37 | Revenue CAGR: 4.00% | SUE: -0.11 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.64 | Chg30d=+0.029 | Revisions Net=+0 | Analysts=4
EPS next Year (2026-12-31): EPS=4.52 | Chg30d=+0.016 | Revisions Net=+1 | Growth EPS=+29.8% | Growth Revenue=+100.0%
Additional Sources for GIL Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle